Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIPHON: Tiotropium on HRQoL in COPD
NCT00274053Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Apr 2002
- Primary completion
- Apr 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Apr 2002; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00274053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274053.